What Is a 510(k)? FDA Clearance Timelines, Costs, and Pitfalls Explained

2026-09-14 · Caduvo Team

A clear-eyed look at the 510(k) premarket notification pathway: substantial equivalence, submission contents, realistic timelines, user fees, and the most common reasons the FDA sends an Additional Information request.

You’ve got a working prototype, benchtop data, and a design freeze date circled on the calendar. The next step: answer what is a 510k and figure out whether your device needs one. The 510(k) pathway is the most common FDA market entry route for medical devices, but too many teams treat it as a paperwork exercise and lose months to avoidable holds. This guide lays out the mechanics—substantial equivalence, submission contents, realistic timelines, user fees, and where submissions typically stall—so you can plan a clearance strategy that runs on facts, not hope.

What Is a 510(k)? Substantial Equivalence in Practice

A 510(k) is a premarket notification submitted to FDA under section 510(k) of the Food, Drug, and Cosmetic Act. Its purpose is to demonstrate that a new device is substantially equivalent to a legally marketed predicate device—one that either was on the market before May 28, 1976, or has itself been cleared through the 510(k) process.

Substantial equivalence does not mean the devices are identical. It means the new device has the same intended use and the same technological characteristics as the predicate, or any differences in technology do not raise new questions of safety and effectiveness. FDA makes a comparative determination, not a standalone safety finding. That’s why the predicate device is the single most important choice in any 510(k) submission. A well-chosen predicate shortens review; a weak one leads straight to a hold letter. For a step-by-step method on selecting and documenting a predicate, see predicate device selection guide.

The outcome is 510(k) clearance, not approval. We’ll return to that distinction shortly.

Who Needs 510(k) Clearance?

Most Class II devices require a 510(k) unless they are explicitly exempt under 21 CFR. Some Class I devices and a small number of unclassified devices also need one. The starting point is to identify your device’s classification regulation and FDA product code. If the product code lists a 510(k) requirement and no exemption, you must submit. If your device is novel and falls into a class that normally requires a 510(k) but you believe it is low-to-moderate risk, you might instead consider the De Novo pathway to get classified without a predicate. A quick reference on class determinations and product codes is in FDA medical device classification.

Practically speaking, if you are developing a device that fits within an existing Class II category—such as a surgical instrument, patient monitor, or diagnostic catheter—and you have a clear predicate, plan on a 510(k).

What Goes Into a 510(k) Submission?

A complete 510(k) submission today is an electronic copy (eCopy) that follows FDA’s Refuse to Accept (RTA) checklist. The core sections:

Every 510k submission must stand on these sections. Omissions, especially around testing, are the top reason FDA issues an Additional Information (AI) request. Think of the RTA checklist as your preflight check: if the submission fails administrative review, it is returned without a substantive review.

Timelines, Fees, and Why You’ll Probably Get an AI Letter

The FDA’s statutory goal under MDUFA V for a traditional 510(k) is 90 days from submission to a final decision. In practice, the clock rarely runs straight through.

Real-world timing from initial submission to final clearance letter often runs 6 to 12 months, depending on how many AI rounds occur and how quickly your team can turn around test reports.

Costs: For FY2024, the standard 510(k) user fee is $19,870. Small businesses (under $100 million in revenue) pay $4,967. But the fee is just the entry ticket. Testing—battery of safety, EMC, biocompatibility, and sometimes clinical performance data—can push the total spend to $50,000–$150,000 or more for a first-time submission.

Where submissions typically stall:

Cleared, Not Approved: Why Words Matter

A 510(k) results in clearance, not approval. Approval is reserved for PMAs, HDEs, and certain other pathways where FDA makes an affirmative determination of safety and effectiveness based on clinical data. When FDA clears a 510(k), it is saying the device is substantially equivalent to a predicate; it is not endorsing the device’s safety and effectiveness from scratch.

This distinction has real consequences. Marketing materials cannot say “FDA approved.” Legal liability theories that rely on FDA approval as a shield fall flat when the device was only cleared. And if your device later requires a PMA due to higher risk, the regulatory bar changes dramatically. For a comparison of clearance and approval pathways, see 510(k) vs PMA vs De Novo.

Actionable Takeaways

Related reading